{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Fludarabine",
  "nciThesaurus": {
    "casRegistry": "21679-14-1",
    "chebiId": "",
    "chemicalFormula": "C10H12FN5O4",
    "definition": "A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth. ",
    "fdaUniiCode": "P2K93U8740",
    "identifier": "C1094",
    "preferredName": "Fludarabine",
    "semanticType": "Nucleic Acid, Nucleoside, or Nucleotide",
    "subclassOf": [
      "C1556",
      "C2150"
    ],
    "synonyms": [
      "2-Fluoro-9-beta-arabinofuranosyladenine",
      "2-Fluorovidarabine",
      "9-Beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine",
      "9-Beta-D-arabinofuranosyl-2-fluoroadenine",
      "FLUDARABINE",
      "Fludarabine",
      "Fluradosa",
      "fludarabine"
    ]
  }
}